These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2509666)

  • 1. Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and intensive conservative therapy.
    Shin K; Nagai Y; Hirano C; Kataoka N; Ono I; Yamamura E; Moriyama C; Horigome Y; Ehara T; Kamoda T
    J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):163-6. PubMed ID: 2509666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
    Lee WS; McKiernan P; Kelly DA
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):575-81. PubMed ID: 15861019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of plasmapheresis for hepatic disorders.
    Hida M; Watanabe J; Tanaka K; Kitamura M; Iida T; Hiraga S; Satoh T; Tanaka S; Kawamura Y; Tanaka M
    Tokai J Exp Clin Med; 1992 Dec; 17(5-6):223-7. PubMed ID: 1343429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmapheresis in the treatment of hepatic coma complicating viral hepatitis].
    Sciborski R; Zubkiewicz-Usnarska L; Groehlich B; Burska-Urbanowicz A; Simon K
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):260-2. PubMed ID: 1437726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome.
    Aydoğdu S; Ozgenç F; Yurtsever S; Akman SA; Tokat Y; Yağci RV
    J Trop Pediatr; 2003 Dec; 49(6):367-70. PubMed ID: 14725414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.
    Okita K; Matsuda S; Hanta T; Yasunaga M; Sanuki K; Takemoto T
    Gastroenterol Jpn; 1987 Oct; 22(5):607-13. PubMed ID: 3315819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fulminant hepatitis in children].
    Durand P; Debray D; Devictor D
    Presse Med; 1996 Oct; 25(31):1501-6. PubMed ID: 8958881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis in the treatment of fulminating hepatitis with coma: 6 case reports].
    Boland J; Broux R; Bury J; Pirotte J
    Acta Clin Belg; 1976; 31(4):173-87. PubMed ID: 1007804
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulminant hepatitis with coma successfully treated by plasmapheresis and hyperimmune Australia-Antibody-rich plasma.
    Lepore MJ; McKenna PJ; Martinez DB; Stutman LJ; Bonanno CA; Conklin EF; Robilotti JG
    Am J Gastroenterol; 1972 Oct; 58(4):381-9. PubMed ID: 4639754
    [No Abstract]   [Full Text] [Related]  

  • 11. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis in acute liver failure.
    Freeman JG; Matthewson K; Record CO
    Int J Artif Organs; 1986 Nov; 9(6):433-8. PubMed ID: 3818118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.
    Kato Y; Nakata K; Omagari K; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Yano M; Eguchi K
    Intern Med; 2001 Jan; 40(1):5-8. PubMed ID: 11201371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis with plasma exchange in hepatic coma. Methods and results in five patients with acute fulminant hepatic necrosis.
    Lepore MJ; Martel AJ
    Ann Intern Med; 1970 Feb; 72(2):165-74. PubMed ID: 5412484
    [No Abstract]   [Full Text] [Related]  

  • 15. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.
    Yoshiba M; Inoue K; Sekiyama K; Koh I
    Artif Organs; 1996 Nov; 20(11):1169-72. PubMed ID: 8908326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow velocity during high volume plasmapheresis in fulminant hepatic failure.
    Larsen FS; Hansen BA; Jørgensen LG; Secher NH; Bondesen S; Linkis P; Hjortrup A; Kirkegaard P; Agerlin N; Kondrup J
    Int J Artif Organs; 1994 Jun; 17(6):353-61. PubMed ID: 7806421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fulminant hepatitis caused by disulfiram].
    Zala G; Schmid M; Bühler H
    Dtsch Med Wochenschr; 1993 Sep; 118(38):1355-60. PubMed ID: 8404476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of plasmapheresis in the treatment of acute liver failure].
    Pavelka A; Dobes L; Dobes P; Lesanic J; Zadrazil J
    Vnitr Lek; 1992 Jan; 38(1):60-5. PubMed ID: 1561776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease.
    Lepore MJ; Stutman LJ; Bonanno CA; Conklin EF; Robilotti JG; McKenna PJ
    Arch Intern Med; 1972 Jun; 129(6):900-7. PubMed ID: 4555940
    [No Abstract]   [Full Text] [Related]  

  • 20. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure.
    Iwai H; Nagaki M; Naito T; Ishiki Y; Murakami N; Sugihara J; Muto Y; Moriwaki H
    Crit Care Med; 1998 May; 26(5):873-6. PubMed ID: 9590317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.